TMF1

TMF1 (ARA160/TMF) is a Golgi-resident golgin that organizes the Golgi apparatus and tethers Rab6-dependent retrograde transport vesicles, thereby governing membrane traffic that underlies several specialized cellular programs (PMID:15128430, PMID:17698061). It binds all three isoforms of the Rab6 GTPase through a conserved coiled-coil motif, concentrates at budding structures at the tips of Golgi cisternae, and is required for retrograde transport of Shiga toxin to the trans-Golgi network and for Golgi retention of GalNAc-T2 (PMID:15128430, PMID:17698061); through interactions with the COG complex and with COPI-stripped Golgi membranes it brings vesicle and target membranes into apposition prior to fusion (PMID:23239882). A microtubule-interacting (MIT) domain anchors TMF1 stably to the Golgi and lets it reorient the Golgi during specialized differentiation (PMID:26701263). These trafficking functions make TMF1 essential in vivo: it is required for homing of pro-acrosomal vesicles to the spermatid nucleus and for acrosome formation during spermiogenesis (PMID:20691678, PMID:26701263), and for the formation of insulin-responsive GLUT4 vesicles at the trans-Golgi, with its loss causing impaired GLUT4 trafficking, reduced glucose uptake, and hyperglycemia (PMID:33475194). Beyond its membrane role, TMF1 acts as an E3 ubiquitin ligase adaptor: under metabolic stress its BC-box motif recruits elongin C to direct ubiquitination and proteasomal degradation of STAT3 and of the NF-κB subunit p65/RelA, attenuating NF-κB target gene expression and tumor xenograft growth (PMID:15467733, PMID:19330832), and this p65 control also tunes MUC2 mucin expression in the colon (PMID:22553199). TMF1 was originally identified as an androgen-enhanced coactivator of the androgen receptor N-terminal domain that cooperates with SWI/SNF chromatin-remodeling ATPases (PMID:10428808, PMID:12044884).

1. 1999 High

   Established the first molecular function for TMF1 by showing it acts as an androgen-dependent transcriptional coactivator, linking the protein to nuclear hormone signaling.

   Evidence Far-Western, Co-IP, pulldown, two-hybrid and reporter assays in prostate cancer cells

   PMID:10428808

   Open questions at the time

   • Did not define the structural basis of AR N-terminal binding
   • Did not reconcile a nuclear coactivator role with later Golgi localization
2. 2002 Medium

   Connected TMF1's coactivator function to chromatin remodeling and revealed dual subcellular distribution, raising the question of how one protein partitions between nucleus and Golgi.

   Evidence Reciprocal Co-IP with domain mapping plus immunofluorescence fractionation

   PMID:12044884

   Open questions at the time

   • Single lab; functional consequence of SWI/SNF binding for transcription not established
   • Mechanism controlling isoform localization unresolved
3. 2004 High

   Defined TMF1 as a bona fide golgin by identifying the Rab6-binding coiled-coil motif and a Golgi-organization phenotype, establishing its membrane-tethering identity.

   Evidence Direct binding assays and RNAi knockdown with immunofluorescence

   PMID:15128430

   Open questions at the time

   • Specific retrograde cargoes not yet defined
   • Modest dispersal phenotype left functional importance unclear
4. 2004 High

   Revealed an unexpected second activity — TMF1 as an E3 ubiquitin ligase adaptor that targets STAT3 — by mapping a BC-box that recruits elongin C.

   Evidence BC-box deletion mutagenesis, Co-IP, and ubiquitination assays under serum deprivation

   PMID:15467733

   Open questions at the time

   • Identity of the full E3 complex (cullin/RBX) not defined
   • Trigger relocating TMF1 to cytoplasm not mechanistically resolved
5. 2007 High

   Demonstrated the cargo-specific role of TMF1 in Rab6-dependent retrograde transport, distinguishing it from bulk Golgi maintenance.

   Evidence Immuno-EM, RNAi, chimeric proteins, and Shiga toxin trafficking assays

   PMID:17698061

   Open questions at the time

   • Why only a subset of Golgi enzymes (GalNAc-T2 vs GalT) require TMF1 retention unexplained
   • Coupling between tethering and fusion machinery not defined
6. 2009 Medium

   Extended the ubiquitin-adaptor function to NF-κB p65/RelA and linked it to suppression of pro-angiogenic gene expression and tumor growth.

   Evidence Ectopic TMF1 expression, ubiquitination assays, and xenograft mouse model with expression profiling

   PMID:19330832

   Open questions at the time

   • Single lab; physiological stress conditions driving p65 degradation not fully defined
   • Selectivity between STAT3 and p65 substrates unresolved
7. 2010 High

   Established the in vivo essentiality of TMF1 for spermiogenesis through a knockout, tying vesicle homing to acrosome biogenesis.

   Evidence TMF1-null mouse with histology, immunofluorescence, and electron microscopy

   PMID:20691678

   Open questions at the time

   • Molecular tether linking pro-acrosomal vesicles to the nuclear surface not identified
   • Did not separate trafficking defect from downstream maturation failures
8. 2012 Medium

   Positioned TMF1 within a tethering architecture by showing the COG complex and Rab GTPases bind both golgin ends, supporting a model that bridges vesicle to target membrane.

   Evidence Interaction-domain mapping and binding to COPI-stripped Golgi membranes

   PMID:23239882

   Open questions at the time

   • Whether bridging directly precedes fusion not demonstrated in vivo
   • Stoichiometry and order of assembly with COG/Rab unknown
9. 2012 Medium

   Showed that TMF1-dependent p65/NF-κB activity governs colonic MUC2 mucin expression, connecting its ubiquitin role to mucosal physiology.

   Evidence TMF1 knockout mouse with DSS colitis, expression analysis, and bacterial colonization assays

   PMID:22553199

   Open questions at the time

   • Direct demonstration that p65 degradation (vs other effects) drives MUC2 change incomplete
   • Cell-autonomy in intestinal epithelium not isolated
10. 2012 Medium

    Linked TMF1 loss to systemic endocrine disruption, indicating its testicular function extends beyond germ cells to hormone homeostasis.

    Evidence TMF1 knockout mouse with hormone measurements and testosterone rescue

    PMID:23000399

    Open questions at the time

    • Whether reduced testosterone is a primary or secondary consequence unresolved
    • Molecular pathway connecting TMF1 to Leydig cell function unknown
11. 2015 High

    Mechanistically explained the spermiogenesis defect by showing TMF1 reorients the Golgi via a microtubule-interacting domain to position vesicles at the nucleus.

    Evidence TMF1 knockout mouse with light and electron microscopy, domain analysis, and microtubule co-sedimentation

    PMID:26701263

    Open questions at the time

    • How the MIT domain coordinates with Rab6 tethering not integrated
    • Regulation of dynamic cis-to-trans relocalization unknown
12. 2021 High

    Generalized the trafficking role to metabolism by showing TMF1 is required for insulin-responsive GLUT4 vesicle formation and glucose homeostasis.

    Evidence TMF1 knockout myoblasts and mice with GLUT4 trafficking, glucose uptake, and blood glucose assays

    PMID:33475194

    Open questions at the time

    • Whether GLUT4 vesicle formation uses the same Rab6/COG machinery as retrograde transport not tested
    • Mechanism of insulin-driven TMF1 upregulation unknown

• How TMF1 partitions and switches between its Golgi-tethering role and its cytoplasmic ubiquitin-adaptor / nuclear coactivator roles, and whether these functions share regulatory inputs, remains unresolved.
• No structural model integrating Rab6 coiled-coil, MIT, and BC-box domains
• Signals controlling subcellular relocalization across functions not defined